TrialOrphanet journal of rare diseases2025

Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study.

Yan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.